Steto creates diabetes digital therapies and remote patient monitoring solutions.
Steto has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
Steto's investors include Bpifrance, AGORANOV.
Steto is headquartered in Paris, France.
Steto creates diabetes digital therapies and remote patient monitoring solutions.
Steto is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Steto — Funding & Investors." VCBacked, November 14, 2023, https://www.vcbacked.co/company/steto. Accessed November 11, 2026.
VCBacked. (2023). Steto — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/steto
{{cite web |title=Steto — Funding & Investors |url=https://www.vcbacked.co/company/steto |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Steto? Request a listing update